Other / review
Medical devices — normothermic organ (liver) perfusion technology
Latest disclosed round
Evidence status
Capital network
Funding record
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2025-05-08 | Equity financing, 2nd private-placement closing (same program as above, incremental new money — not a fresh priced round) | ~$18M incremental (brought the financing program's cumulative total to $160M) | New: Intuitive Ventures, Terumo Ventures, Piper Heartland Healthcare LLC |
| 2025-02-24 | Equity financing, 1st closing | $142M | HealthQuest Capital (new), Existing: BGF (£20M of this round specifically), Lauxera Capital Partners, University of Oxford, Technikos, Oxford Technology and Innovations Fund, Longwall Ventures. New: Sofina, Soleus Capital, Avidity Partners |
| 2023-07-17 | Growth round (aggregators label this 'Series D') | £25M (reported as $32.6-32.7M) | Lauxera Capital Partners, Existing investors (not individually named in the release) |
| 2020-01-08 | BGF follow-on | £4.6M (~$5.36M) | BGF |
| 2019 | BGF first investment (label uncertain — inferred later 'Series C'-equivalent by sequence) | undisclosed | BGF |
| 2013-2014 | Follow-on round (label uncertain — inferred later 'Series B'-equivalent by sequence, not an explicit company label) | just under £1 million (imprecise per source) | Longwall Venture Partners (continuing, no lead explicitly named) |
| 2008 | Seed / proof-of-concept | £250,000 | University Challenge Seed Fund |
| 2008 | Early round (Oxford University Innovation calls it 'seed'; one outlet's headline calls it 'Series A') | £1.5M | Technikos, Oxford Technology Management Ltd (later Longwall Ventures) |
Traceability
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.